The Anti-VEGFA Bevacizu Biosimilar (HDBS0059) is a highly specific and reliable monoclonal antibody designed for research involving Vascular Endothelial Growth Factor A (VEGFA), a key player in angiogenesis and tumor growth. This biosimilar antibody, derived from Bevacizumab, is produced using advanced technology to ensure high affinity and specificity for VEGFA.The Anti-VEGFA Bevacizu Biosimilar (HDBS0059) is validated for use in various applications, including ELISA, immunohistochemistry, and flow cytometry, making it versatile for different research needs. It specifically targets VEGFA, enabling precise detection and analysis in cancer cells and tissues, making it an essential tool for studies in oncology and angiogenesis.
Given the vital role of VEGFA in promoting tumor angiogenesis and progression, understanding its mechanisms and regulation is crucial for developing targeted therapies in cancer treatment. The Anti-VEGFA Bevacizu Biosimilar (HDBS0059) provides researchers with a valuable tool to further explore the relationship between VEGFA and tumor development, ultimately leading to potential breakthroughs in cancer therapy.
Product Name:
Bevacizumab (Anti-VEGFA) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0059
Target:
VEGFA
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MVCD1,VEGF,VPF
Description:
Anti-VEGFA Reference mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
